MitoCarta 3.0 Comparative Synteny

Broad MitoCarta 3.0 vs. Plant Mitochondrial Proteome

Cross-kingdom comparative synthesis aligning the 1,136 human genes and 149 MitoPathways from MitoCarta 3.0 (Rath et al. 2021) against the Arabidopsis thaliana plant mitochondrial proteome. Explore four evolutionary quadrants, the interactive Complex I holo-assembly alignment, and taxonomic conservation across 1.8 billion years of endosymbiotic history.

Q1: Strict Orthologs Conserved Core

Catalytic cores of Complexes I–V, TCA cycle enzymes, Fe-S ISC assembly machinery. Catalytic active sites and electron relay wires are identical.

Q2: Plant Innovations Bypasses

Alternative Oxidase (AOX), Type II rotenone-insensitive NDHs, Complex I CA domain, GDC photorespiration. Completely absent in mammals.

Q3: Dual-Targeted Divergence Shared Machinery

Organellar DNA polymerases (PolIA/B), RecA, and tRNA synthetases dual-targeted to BOTH mitochondria and chloroplasts for coordinated maintenance.

Q4: Expanded Plant Families PPR & Solute Carriers

PPR RNA-editing family (>450 genes in plants vs 7 in humans) required for massive ~500 C-to-U organellar RNA edits and photosynthetic cross-talk.

Interactive Complex I Holo-Assembly Synteny: Mammal (45 Subunits) vs. Plant (51 Subunits)

Inspect structural subunit composition, catalytic mechanisms, and the plant-specific matrix Carbonic Anhydrase (CA) protuberance absent in mammals.

All Holo-Complex I Modules & Alternative Bypasses

Comparative HUD

Mammalian Subunits (Homo sapiens)

45 subunits (7 mtDNA-encoded, 38 nuclear-encoded) • ~970 kDa

Plant Orthologs (Arabidopsis thaliana)

51 subunits (9 mtDNA-encoded, 42 nuclear-encoded) • ~1,000 kDa

Catalytic Mechanism & Stoichiometry

NADH + H⁺ + Q + 4 H⁺_matrix → NAD⁺ + QH₂ + 4 H⁺_IMS. Plant Complex I features an auxiliary matrix Carbonic Anhydrase protuberance and bypass enzymes (AOX1a, NDB2, NDA1).

Human Clinical Disease Association

Complex I deficiency is the most frequent cause of mitochondrial disease (~30% of cases), causing Leigh syndrome, fatal infantile lactic acidosis, and LHON.

Plant Physiological Role & Stress Significance

Dual metabolic flexibility: under photorespiration or spaceflight stress, excess reducing equivalents bypass Complex I via AOX/NDB2, preventing lethal ROS generation.

Evolutionary Trajectory of the Mitochondrial Proteome (1.8 Ga to Present)

Trace endosymbiotic origins, organellar gene transfer (EGT), land colonization adaptations, and mammalian streamlining across 6 major evolutionary epochs.

α-Proteobacteria Endosymbiosis (~1.8 Billion Years Ago)

Evolutionary Milestone

Evolutionary Transition

Free-living bacterium related to Rickettsiales engulfed by Asgard archaeon host.

Key Bioenergetic Innovations

Ancestral proton-pumping electron transport chain (Complexes I, II, III, IV, V), complete oxidative phosphorylation, and TCA cycle.

Genome Architecture & Gene Transfer

Circular bacterial genome (~1.5 Mb). Massive Endosymbiotic Gene Transfer (EGT) to host nucleus begins, founding organellar signaling.

💡

Translational Spotlight: Xenotopic Expression of Plant Enzymes Rescues Human Mitochondrial Disease

Because mammals completely lost non-proton pumping respiratory enzymes, mitochondrial defects in human Complex I or Complex III/IV cause fatal respiratory arrest, severe lactic acidosis, and early death (e.g. Leigh syndrome). Groundbreaking studies have shown that xenotopic expression of plant Alternative Oxidase (AOX1a) or plant Type II NADH dehydrogenase (NDB2) in human patient cybrids and mouse disease models acts as an artificial electron bypass:

Circumventing Complex III/IV Blockades: Plant AOX accepts electrons directly from reduced ubiquinol (QH₂) and donates them directly to O₂, completely restoring electron flux and preventing catastrophic superoxide generation in human cells (Hakkaart et al. 2006 EMBO Rep).
Treating Fatal Myopathies: In mouse models of mitochondrial encephalomyopathy and cardiac ischemia, AOX transgene expression prevented sudden heart failure, decreased brain lesions, and restored normal motor performance (El-Khoury et al. 2014 Cell Death Dis; Cannino et al. 2012 Hum Mol Genet).

Interactive Quadrant Navigator & Ortholog Synteny Explorer

Search and filter curated human MitoCarta 3.0 loci vs Arabidopsis homologs across all four evolutionary quadrants with real-time sequence identity gating.

Min Identity: 0%

Showing 14 / 14 ortholog pairs • Mean Identity: 47.9%

Human Gene	Arabidopsis Locus	Quadrant	Identity	Human Clinical Phenotype	Evolutionary Inference & Significance
NDUFA9	AT5G08530 (NDUFA9)	Q1: Strict Ortholog	58.4%	Human mutations cause Leigh syndrome and fatal infantile lactic acidosis.	Catalytic NADH-dehydrogenase core structure identical; plant protein co-assembles with CA-domain protuberance.
SDHA	AT5G66760 (SDH1-1)	Q1: Strict Ortholog	72.1%	Human mutations cause Leigh syndrome, cardiomyopathy, paraganglioma.	Conserved FAD-binding flavoprotein subunit coupling succinate oxidation to ubiquinone pool reduction.
UQCRFS1	AT5G13440 (RIESKE)	Q1: Strict Ortholog	64.3%	Human mutations cause Complex III deficiency with exercise intolerance.	Conserved [2Fe-2S] cluster mediating the first electron transfer of the Q-cycle.
GLDC	AT4G33010 (GDCP)	Q1: Strict Ortholog	62.8%	Human mutations cause nonketotic hyperglycinemia with severe neurological impairment.	In plants, GDCP expression is photo-regulated and massive, driving 3-organelle photorespiratory nitrogen cycling.
POLG	AT1G50840 (PolIA)	Q3: Dual-Targeted	34.2%	Human mutations cause Alpers-Huttenlocher syndrome, PEO, sensory ataxic neuropathy.	Human POLG is dedicated strictly to mitochondria; plant PolIA is dual-targeted to both mitochondria and chloroplasts, synchronizing genome maintenance across both endosymbionts.
None (Plant Innovation)	AT3G22370 (AOX1a)	Q2: Plant Innovation	0.0%	Absent in mammals. Expression of plant AOX in human cybrids or mice rescues Complex I and III deficiencies!	Plant-specific non-proton-pumping terminal oxidase. Acts as a therapeutic bypass when transferred to mammalian disease models.
COX4I1	AT3G15640 (COX5b-1)	Q1: Strict Ortholog	61.2%	Human mutations cause mitochondrial complex IV deficiency, Leigh syndrome, and lactic acidosis.	Catalytic cytochrome c oxidase regulatory subunit in the terminal respiratory complex.
ATP5F1B	AT5G13450 (ATP5)	Q1: Strict Ortholog	68.5%	Human mutations cause mitochondrial encephalopathy and episodic metabolic decompensation.	Rotary catalytic F1-domain beta subunit coupling proton flux to ATP synthesis.
CS	AT2G36070 (CSY2)	Q1: Strict Ortholog	59.4%	Human mutations disrupt the mitochondrial tricarboxylic acid cycle initiating flux.	Catalyzes oxaloacetate and acetyl-CoA condensation; non-cyclic flux in illuminated leaves.
None (Plant Innovation)	AT1G47260 (CAL1)	Q2: Plant Innovation	0.0%	Completely absent in mammals. Required for plant holo-Complex I super-assembly stability.	Forms matrix-facing Carbonic Anhydrase-like protuberance essential for OXPHOS assembly and male fertility.
None (Plant Innovation)	AT4G05020 (NDB2)	Q2: Plant Innovation	0.0%	Absent in mammals. Xenotopic expression in human cybrids bypasses rotenone Complex I blockade.	External rotenone-insensitive NADH dehydrogenase oxidizing cytosolic NADH without proton pumping.
RAD51C	AT1G79050 (RecA1)	Q3: Dual-Targeted	41.5%	Human RAD51 defects cause Fanconi anemia and severe genomic instability.	Dual-targeted to BOTH mitochondria and chloroplasts; drives homologous recombination repair across massive plant organellar genomes.
LRPPRC	AT2G31490 (GUN1)	Q4: Expanded Family	28.6%	Human mutations cause French-Canadian type Leigh syndrome with severe COX deficiency.	Mammals harbor only ~7 PPR proteins; plants expanded the family to >450 members to edit ~500 C-to-U organellar RNA sites.
SLC25A10	AT5G19760 (DTC)	Q4: Expanded Family	54.2%	Human mutations impair dicarboxylate transport, fatty acid synthesis, and gluconeogenesis.	Dicarboxylate/tricarboxylate carrier; plant lineage expanded mitochondrial carrier family (MCF) for photosynthetic cross-talk.

Core MitoPathways Alignment: Human vs. Plant Proteomes

Conservation scores, structural stoichiometries, and plant-specific bypass augmentations across major bioenergetic modules.

MitoPathway Name	Category	Conservation	Plant-Specific Features & Bypasses
Complex I (NADH:ubiquinone oxidoreductase)	OXPHOS	82%	Plant Complex I carries a unique matrix-facing Carbonic Anhydrase-like (CA) domain (CAL1/2, CA1/2/3) required for assembly.
Complex II (Succinate dehydrogenase)	OXPHOS	95%	Extremely high sequence and structural conservation; catalytic SDHA shared between kingdoms.
Complex III (Cytochrome bc1 complex)	OXPHOS	88%	Q-cycle mechanism identical; plant Rieske Fe-S subunit carries conserved 2Fe-2S center.
Complex IV (Cytochrome c oxidase)	OXPHOS	85%	Core 3 catalytic subunits encoded in mitochondrial genome in both kingdoms; plant complex lacks mammalian tissue-specific isoforms.
Complex V (ATP synthase)	OXPHOS	91%	Rotary F1F0 catalysis conserved; c-ring stoichiometry slightly varies.
Alternative Respiratory Pathways (AOX & Type II NDHs)	OXPHOS	0%	Completely absent in mammals. Non-proton pumping quinol oxidases and NADH dehydrogenases prevent over-reduction and ROS under stress.
Tricarboxylic Acid (TCA) Cycle	Metabolism	92%	Core enzymes conserved, but plant TCA cycle is open and non-cyclic in illuminated leaves, prioritizing citrate/malate export for nitrogen assimilation and retrograde signaling.
Photorespiration & Glycine Cleavage	Metabolism	86%	Human glycine cleavage system is low-abundance; in plants, GDC comprises up to 50% of soluble matrix protein, tightly coupled to chloroplast RuBisCO oxygenation.
mtDNA Replication & Maintenance	Mitochondrial Central Dogma	45%	Human POLG is strictly mitochondrial; plant PolIA and PolIB are dual-targeted to BOTH mitochondria and chloroplasts. Plant mtDNA is massive (367 kb vs 16.5 kb human) and recombines actively via RecA.